
Calendar invite, but make it investor-grade
Boston Scientific is teeing up a busy May 27th: the medtech company says it will participate in Bernstein’s 42nd Annual Strategic Decisions Conference and hold a call discussing second-quarter 2026 results. In other words, this is your polite little heads-up that earnings season is coming around the corner.
Why you should care
Conference appearances can be nice for the slide deck crowd, but the real juice here is the earnings call. That’s where investors usually get the fresh read on demand, margins, guidance, and whether the company is still humming along like a well-oiled stent machine.
The setup
Here’s the important part:
- Boston Scientific will participate in Bernstein’s conference on May 27th
- The company will also discuss second-quarter 2026 results that day
- That makes this a clear earnings-calendar marker, not just a networking cameo
Big picture: this is less about what was said at the conference and more about getting BSX on your radar before the actual numbers drop.
